{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:29:03Z","timestamp":1777120143878,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/spc.0b013e328359b668","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:23:31Z","timestamp":1371158611000},"page":"424-431","source":"Crossref","is-referenced-by-count":41,"title":["Evidence base for multimodal therapy in cachexia"],"prefix":"10.1097","volume":"6","author":[{"given":"Tora S.","family":"Solheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.A.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic nonsmall-cell lung cancer.","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus.","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem.","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1200\/JCO.2005.01.8010","article-title":"Systematic review of the treatment of cancer-associated anorexia and weight loss.","volume":"23","author":"Yavuzsen","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1011156811739","article-title":"High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.","volume":"12","author":"Maltoni","year":"2001","journal-title":"Ann Oncol"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","article-title":"N-3 fatty acids, cancer and cachexia: a systematic review of the literature.","volume":"97","author":"Colomer","year":"2007","journal-title":"Br J Nutr"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpainsymman.2008.06.005","article-title":"Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated fatty acids in the management of symptoms, survival, and quality of life.","volume":"37","author":"Mazzotta","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0269216311418709","article-title":"A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project.","volume":"26","author":"Ries","year":"2012","journal-title":"Palliat Med"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/bjc.2011.391","article-title":"Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia.","volume":"105","author":"Murphy","year":"2011","journal-title":"Br J Cancer"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clnu.2011.08.008","article-title":"Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer.","volume":"31","author":"Awad","year":"2012","journal-title":"Clin Nutr"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00520-005-0905-5","article-title":"A meta-analysis of exercise interventions among people treated for cancer.","volume":"14","author":"Conn","year":"2006","journal-title":"Support Care Cancer"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-04-0703","article-title":"Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.","volume":"14","author":"Schmitz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion.","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"R20-3-20211004","first-page":"27","article-title":"Physical activity as a supportive care intervention in palliative cancer patients: a systematic review.","volume":"7","author":"Lowe","year":"2009","journal-title":"J Support Oncol"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1634\/theoncologist.2011-0133","article-title":"Physical exercise for cancer patients with advanced disease: a randomized controlled trial.","volume":"16","author":"Oldervoll","year":"2011","journal-title":"Oncologist"},{"key":"R22-3-20211004","first-page":"10","article-title":"Physical activity interests and preferences in palliative cancer patients.","volume":"10","author":"Lowe","year":"2009","journal-title":"Support Care Cancer"},{"key":"R23-3-20211004","first-page":"243","article-title":"Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care.","volume":"54","author":"Bovio","year":"2008","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ajcn\/84.5.1163","article-title":"Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy.","volume":"84","author":"Hutton","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.1332","article-title":"Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients.","volume":"93","author":"Bosaeus","year":"2001","journal-title":"Int J Cancer"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/gast.2001.28031","article-title":"AGA technical review on parenteral nutrition.","volume":"121","author":"Koretz","year":"2001","journal-title":"Gastroenterology"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2005.02.054","article-title":"Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy.","volume":"23","author":"Ravasco","year":"2005","journal-title":"J Clin Oncol"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hed.20221","article-title":"Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.","volume":"27","author":"Ravasco","year":"2005","journal-title":"Head Neck"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.bjc.6601962","article-title":"Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area.","volume":"91","author":"Isenring","year":"2004","journal-title":"Br J Cancer"},{"key":"R32-3-20211004","first-page":"205","article-title":"Nutritional evaluation and dietetic care in cancer patients treated with radiotherapy: prospective study.","volume":"7","author":"Macia","year":"1991","journal-title":"Nutrition"},{"key":"R33-3-20211004","first-page":"2303","article-title":"Dietary information after radiotherapy of head and neck cancer.","volume":"116","author":"Lovik","year":"1996","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clnu.2004.11.003","article-title":"Diet energy density and energy intake in palliative care cancer patients.","volume":"24","author":"Wallengren","year":"2005","journal-title":"Clin Nutr"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/bjc.1997.463","article-title":"A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients.","volume":"76","author":"McMillan","year":"1997","journal-title":"Br J Cancer"},{"key":"R36-3-20211004","first-page":"5374","article-title":"Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.","volume":"58","author":"Daneryd","year":"1998","journal-title":"Cancer Res"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","article-title":"A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.","volume":"79","author":"McMillan","year":"1999","journal-title":"Br J Cancer"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpainsymman.2003.05.010","article-title":"Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study.","volume":"27","author":"Cerchietti","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","article-title":"An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.","volume":"22","author":"Jatoi","year":"2004","journal-title":"J Clin Oncol"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/1055-9965.EPI-05-0538","article-title":"A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anticyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexiacachexia and oxidative stress.","volume":"15","author":"Mantovani","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/01635580701365068","article-title":"Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.","volume":"59","author":"Cerchietti","year":"2007","journal-title":"Nutr Cancer"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.20160","article-title":"Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function.","volume":"100","author":"Lundholm","year":"2004","journal-title":"Cancer"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","article-title":"Randomized phase III clinical trial of a combined treatment with carnitine celecoxib megestrol acetate for patients with cancer-related anorexiacachexia syndrome.","volume":"31","author":"Madeddu","year":"2012","journal-title":"Clin Nutr"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","article-title":"A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.","volume":"124","author":"Maccio","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCO.0b013e328352a895","article-title":"Terminology in cancer cachexia: importance and status.","volume":"15","author":"Macdonald","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R48-3-20211004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/1471-2407-11-493","article-title":"A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients: ACCeRT study.","volume":"11","author":"Rogers","year":"2011","journal-title":"BMC Cancer"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201212000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T03:25:07Z","timestamp":1633490707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201212000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e328359b668","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}